Join Now

Category Archives: BioUtah News

New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

Dan Albertson, MD, will serve as president of the University Business Unit.

| Tagged | Comments Off on New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

Varex Imaging has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.

| Tagged | Comments Off on VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

New Survey Reveals Patients Receive Too Many Needlesticks

Most Americans Unaware of Challenges from Common Hospital Procedures

| Tagged | Comments Off on New Survey Reveals Patients Receive Too Many Needlesticks

BD Named Among Fortune’s Most Innovative Companies

BD Named Among Fortune’s Most Innovative Companies

| Tagged | Comments Off on BD Named Among Fortune’s Most Innovative Companies

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

| Tagged | Comments Off on Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of Life

| Tagged | Comments Off on PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

| Tagged | Comments Off on Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors

SALT LAKE CITY, UT, March 19, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, is pleased to announce the appointment of Michael Paul, PhD to its Board of Directors, effective March 18, 2024. With decades of experience in life sciences innovation, capital formation, […]

| Comments Off on Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen its ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to market. U.S. patent […]

| Comments Off on Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers

HEBER CITY, Utah, Feb. 13, 2024 /PRNewswire/ — Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. The technique is amplification and bisulfite conversion free, effectively bypassing the most common limitations of targeted methylation analysis […]

| Comments Off on Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Presentation included announcement of the opening of the new manufacturing facility in Salt Lake City, UT SALT LAKE CITY, March 21, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that in his keynote address […]

| Comments Off on Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

NUSANO TO PRESENT ISOTOPE PRODUCTION CAPABILITIES AND COMMERCIALIZATION PLANS AT 7TH THERANOSTICS WORLD CONGRESS

VALENCIA, Calif. – March 20, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, will present at the 7th Theranostics World Congress taking place March 22-24, 2024, in Santiago, Chile. Greg Moffitt, Nusano Director of Target Development, will provide an overview of the company’s proprietary radioisotope production platform on Sunday, March 24. […]

| Comments Off on NUSANO TO PRESENT ISOTOPE PRODUCTION CAPABILITIES AND COMMERCIALIZATION PLANS AT 7TH THERANOSTICS WORLD CONGRESS